Objective: The objective of this study was to perform a hip structure analysis (HSA) of teriparatide (TPTD) treatment in women with postmenopausal osteoporosis.
Methods: The study included 96 patients with postmenopausal osteoporosis and received 20 μg TPTD daily. HSA was performed by dual-energy X-ray absorptiometry.
Results: The percent changes from baseline for the cross-sectional moment of inertia, section modulus, buckling ratio, and femoral strength index based on HSA results were 9.8% (p < 0.01), 10.7%, 3.3%, and 14.9% (p < 0.01), respectively, at 24 months.
Conclusion: Based on the HSA results obtained with DXA, TPTD was effective for hip structures.
Keywords: Dual-energy X-ray absorptiometry; Hip structure analysis; Osteoporosis; Rheumatoid arthritis; Teriparatide.